Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Prevalence and Associated Mortality of Infections by Multidrug-Resistant Organisms in Adults Intensive Care Units in Argentina (PREV-AR)
OBSERVATIONAL
Inicio: 24 de nov de 2023
ID: NCT06574776
Terminado
Fase 3
ClinicalTrials.gov
SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavi/r IN Race/Gender HIV+ Patients Randomized to Therapeutic Drug Monitoring or Standard of Care
INTERVENTIONAL
Inicio: 1 de feb de 2007
ID: NCT00440271
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled Study to Investigate Chronic Intermittent-pulse-therapy of Moxifloxacin as a Prevention of Acute in Exacerbation Out-patients With Chronic Bronchitis.
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00473460
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections
INTERVENTIONAL
Inicio: 1 de nov de 2001
ID: NCT00035425
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of DEB025/Alisporivir in Combination With Peg-IFNα2a and Ribavirin in Hepatitis C Genotype 1 Treatment-naïve Patients
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01318694
Reclutando
Fase 3
ClinicalTrials.gov
An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19
INTERVENTIONAL
Inicio: 6 de ago de 2021
ID: NCT04910269
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline Versus Ertapenem for the Treatment of Foot Infections in Subjects With Diabetes
INTERVENTIONAL
Inicio: 1 de ene de 2007
ID: NCT00366249
Completado
ClinicalTrials.gov
Assessment of Mercury Levels and Metabolism in Premature and Low Birth Weight (LBW) Infants Receiving Vaccines Containing Thimerosal
OBSERVATIONAL
Inicio: 1 de dic de 2005
ID: NCT00138333
Completado
ClinicalTrials.gov
Epidemiology of Weaning From Invasive Mechanical Ventilation in COVID-19. Observational and Multicenter Study.
OBSERVATIONAL
Inicio: 1 de abr de 2020
ID: NCT05049200
Desconocido
ClinicalTrials.gov
Institutional COVID-19 Patient Registry
OBSERVATIONAL
Inicio: 14 de abr de 2020
ID: NCT04839107
Completado
ClinicalTrials.gov
PRactice of VENTilation in Patients With ARDS Due to COVID-19 Versus ARDS Due to Other Pulmonary Infections (PRoVENT-COP)
OBSERVATIONAL
Inicio: 1 de ago de 2022
ID: NCT05650957
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of IV to Oral 6-Day TR-701 Free Acid and IV to Oral 10-Day Linezolid for the Treatment of ABSSSI
INTERVENTIONAL
Inicio: 15 de sept de 2011
ID: NCT01421511
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Ceftriaxone, With Adjunctive Clarithromycin, in the Treatment of Adult Subjects With Community-Acquired Pneumonia
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00621504
Completado
ClinicalTrials.gov
Bacterial Infections in Patients with Cirrhosis in Argentina
OBSERVATIONAL
Inicio: 16 de oct de 2018
ID: NCT03919032
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
INTERVENTIONAL
Inicio: 6 de jun de 2024
ID: NCT06056297
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Saroglitazar Magnesium in Subjects With Nonalcoholic Steatohepatitis and Fibrosis
INTERVENTIONAL
Inicio: 18 de ago de 2021
ID: NCT05011305
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 3, Multicenter Trial Investigating the Efficacy and Safety of C21 as add-on to Standard of Care in Adult Subjects With COVID-19
INTERVENTIONAL
Inicio: 16 de sept de 2021
ID: NCT04880642
Completado
Fase 3
ClinicalTrials.gov
A Global Multicenter, Randomized, Double-blind, Placebo -Controlled, Adaptive Designed Phase Ⅲ Clinical Trial to Evaluate the Efficacy, Safety and Immunogenicity of Ad5-nCoV in Adults 18 Years of Age and Older
INTERVENTIONAL
Inicio: 15 de sept de 2020
ID: NCT04526990
Completado
Fase 3
ClinicalTrials.gov
A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants
INTERVENTIONAL
Inicio: 7 de abr de 2021
ID: NCT04767373
Reclutando
ClinicalTrials.gov
Careful Ventilation in Acute Respiratory Distress Syndrome
INTERVENTIONAL
Inicio: 23 de nov de 2020
ID: NCT03963622
Anterior
1
...
28
29
30
...
434
Siguiente
Filtros